EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner
Journal Article
Overview
publication date
- December 3, 2024
has subject area
- Adnexal Diseases - Ovarian Neoplasms
- Animals
- Antigens, Surface - Histocompatibility Antigens
- Antineoplastic Agents - Poly(ADP-ribose) Polymerase Inhibitors
- Cell Line - Cell Line, Tumor
- Cells - CD8-Positive T-Lymphocytes
- Drug Resistance, Neoplasm
- Endocrine System Diseases - Ovarian Neoplasms
- Enzyme Inhibitors - Poly(ADP-ribose) Polymerase Inhibitors
- Female
- Female Urogenital Diseases - Ovarian Neoplasms
- Gonadal Disorders - Ovarian Neoplasms
- Hemic and Immune Systems - CD8-Positive T-Lymphocytes
- Histone-Lysine N-Methyltransferase
- Humans
- Immune System - CD8-Positive T-Lymphocytes
- Isoantigens - Histocompatibility Antigens
- Mice
- Neoplasms by Site - Ovarian Neoplasms
- Tumor Cells, Cultured - Cell Line, Tumor
has restriction
- closed
Date in CU Experts
- August 23, 2024 9:45 AM
Full Author List
- Nguyen LL; Watson ZL; Ortega R; Woodruff ER; Jordan KR; Iwanaga R; Yamamoto TM; Bailey CA; To F; Lin S
author count
- 18
citation count
- 0
published in
- Molecular Cancer Research Journal
Other Profiles
International Standard Serial Number (ISSN)
- 1541-7786
Electronic International Standard Serial Number (EISSN)
- 1557-3125
Digital Object Identifier (DOI)
Additional Document Info
start page
- 1117
end page
- 1127
volume
- 22
issue
- 12